Denali Therapeutics Inc. (DNLI)

SEC filing

Denali Therapeutics Inc.

DNLI · CIK 1714899

4 · Sep 9, 2026 · Chief Medical Officer Chin Peter Scott sold 1,654 shares at $22.29/share ($36,868)

Chief Medical Officer Chin Peter Scott sold 1,654 shares at $22.29/share ($36,868)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.